Movatterモバイル変換

[0]ホーム
URL:

WO2006066103B1 - Ophthalmic implant for treatment of glaucoma - Google Patents

Ophthalmic implant for treatment of glaucoma

Info

Publication number
WO2006066103B1
WO2006066103B1PCT/US2005/045675US2005045675WWO2006066103B1WO 2006066103 B1WO2006066103 B1WO 2006066103B1US 2005045675 WUS2005045675 WUS 2005045675WWO 2006066103 B1WO2006066103 B1WO 2006066103B1
Authority
WO
WIPO (PCT)
Prior art keywords
implant
implant according
canal
wall
tension
Prior art date
Application number
PCT/US2005/045675
Other languages
French (fr)
Other versions
WO2006066103A2 (en
WO2006066103A3 (en
Inventor
Robert Stegmann
Stanley R Conston
David J Kupiecki
John Mckenzie
Candice D Pinson
Ronald Yamamoto
Original Assignee
Iscience Surgical Corp
Robert Stegmann
Stanley R Conston
David J Kupiecki
John Mckenzie
Candice D Pinson
Ronald Yamamoto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=36587389&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2006066103(B1)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Iscience Surgical Corp, Robert Stegmann, Stanley R Conston, David J Kupiecki, John Mckenzie, Candice D Pinson, Ronald YamamotofiledCriticalIscience Surgical Corp
Priority to CA2592459ApriorityCriticalpatent/CA2592459C/en
Priority to DE05854403Tprioritypatent/DE05854403T1/en
Priority to JP2007546947Aprioritypatent/JP5060960B6/en
Priority to EP05854403Aprioritypatent/EP1833440B1/en
Priority to AU2005316420Aprioritypatent/AU2005316420B2/en
Priority to BRPI0519087Aprioritypatent/BRPI0519087B8/en
Publication of WO2006066103A2publicationCriticalpatent/WO2006066103A2/en
Publication of WO2006066103A3publicationCriticalpatent/WO2006066103A3/en
Publication of WO2006066103B1publicationCriticalpatent/WO2006066103B1/en

Links

Classifications

Landscapes

Abstract

An implant (11) is placed within Schlemm's canal of the eye and provides tension to the trabecular meshwork. The tension (12) is continuous and increases the aqueous outflow without the necessity of administering cholinergic drugs to treat glaucoma.

Claims

AMENDED CLAIMS received by the International Bureau on 01 September 2006 (01.09.2006)What is claimed is:
1. An implant for the treatment of glaucoma comprising an elongated element with distal and proximal ends, said element being a size sufficient to be inserted within Schlemm's canal of the eye and having a sufficient shape and mechanical stiffness such that application of an axial tensioning force to said element provides a tension to the inner wall of the canal to thereby increase fluid permeability of said inner wall.
2. An implant for the treatment of glaucoma comprising an elongated element with distal and proximal ends, said element being a size sufficient to be inserted within Schlemm's canal of the eye and comprising a securing element at said one or both of said ends, said securing element attached to a tensioning element providing an axial tensioning force to said elongated element to apply tension to the inner wall of the canal to thereby increase fluid permeability of said inner wall.
3. An implant according to Claim 2 wherein said tensioning element comprises a spring.
4. An implant according to Claim 2 wherein said tensioning element is accommodated in a protecting housing.
5. An implant according to Claim 2 wherein said tensioning element comprises a crimping element for securing said implant in a tensioned position.
6. An implant according to Claim 1 wherein said elongated element comprises a helical filament
7. An implant according to Claim 1 comprising at least two of said elongated elements twisted together in a helical manner.
8. An implant according to Claim 1 comprising at least two of said elongated elements fixed in a parallel manner.
9. An implant according to Claim 1 wherein said elongated element comprises a serpentine filament having a circular cross-sectional aspect
10. AJQ implant according to Claim 1 wherein said elongated element comprises a serpentine filament having an ovoid cross-sectional aspect.
11. An implant according to Claim 9 ox 10 wherein said filament comprises a series of loops.
12. An implant according to Claim 1 wherein said elongated element comprises first regions of a first cross-sectional dimension interspaced with second regions of a second cross-sectional dimension wherein said first cross-sectional dimension is larger than said second cross-sectional dimension.
13. An implant according to Claim 12 wherein said first regions comprise heads.
14. An implant according to Claim 12 wherein said first regions comprise cylindrical segments.
15. An implant according to Claim 12 wherein said first regions freely rotate relative to said second regions.
16. An implant according to Claim 1 wherein said elongated element comprises filament loops connected to an axial element.
17. An implant according to Claim 1 wherein said elongated element comprises filament loops connected at alternating ends.
18. An implant according to Claim 1 wherein said elongated element is provided with a shape to promote flow of aqueous humor from the inner wall of said canal to the collector channels on the outer wall of said canal,
19. An implant according to Claim 18 wherein said shape comprises multiple angular bends resembling a saw-tooth profile.
20. An implant according to Claim 18 wherein said shape comprises repeating semicircular profiles.
21. An implant according to Claim 18 wherein said shape comprises a helical filament
22. An implant according to Claim 18 wherein said shape comprises a tube with internal channels.
23. AQ implant according to Claim 2 wherein said securing element comprises a ring.
24. An implant according to Claim 2 wherein said tensioning element comprises a spring.
25. An implant according to Claim 2 wherein said tensioning element comprises an elastic element providing 4 to 6 grams force per mm change in length.
26. An implant according to Claim 2 wherein said securing element comprises a clamp.
27. An implant according to Claim 2 wherein said securing element allows adjustment of the length of said implant
28. An implant according to Claim 1 provided with an expanded tip to dilate said canal.
29. An implant according to Claim 1 comprising a metal.
30. An implant according to Claim 1 comprising a biocompatible polymer.
31. An implant according to Claim 1 comprising a biologically active agent.
32. An implant according to Claim 31 wherein said biologically active agent is selected from the group consisting of an anti-thrombogenic agent, anti-microbial agent, antiinflammatory agent, anti-fibrotic agent, anti-cell proliferative agent and anti-adhesion agent.
33. An implant according to Claim 32 wherein said biologically active agent is selected from the group consisting of heparin, tissue plasminogen activator, a steroid, an antimicrobial agent, hyaluronic acid, rapamycin, paclitaxol, 5-fluorouracil, mitomycin and methotrexate.
34. An implant according to Claim 1 wherein said tensioning force is in the range of about 0.027 to 0.292 grams force per mm arc length of said canal,
35. An implant according to Claim 34 wherein said tensioning force is in the range of about 0.159 to 0.265 grams force per mm arc length of said canal.
36. Aa implant according to Claim 1 or 2 wherein said ends are connected with a tensioning force in the range of about 1 to 11 grams.
37. An implant according to Claim 36 wherein said ends are connected with a tensioning force in the range of about 6 to 10 grams.
38. A tool for insertion of an implant into Schlemm's canal of the eye comprising an implant according to Claim 1 or 2 attached to a flexible cannula,
39. A tool for insertion of an implant into Schlemm's canal of the eye comprising an implant according to Claim 1 or 2 attached to a guidewire.
40. A tool according to Claim 38 further comprising a mechanical element on said cannula for attachment of said implant to said cannula.
41. A tool according to Claim 40 wherein said mechanical element comprises a hole, slot, or an area of increased diameter at a tip of said cannula.
42. A tool according to Claim 38 further comprising a guidance element for locating said tool during placement and advancement within Schlemm's canal.
43. A tool according to Claim 42 wherein said guidance element comprises a fiber optic beacon.
44. A tool according to Claim 38 further comprising an expandable mechanical element for dilating said canal.
45. A tool according to Claim 38 further comprising a lumen for injection of viscous materials.
46, A tool according to Claim 38 further comprising a lubricious coating.
47, A tool according to Claim 38 wherein said cannula comprises a rounded tip.
48. A method for increasing the aqueous outflow of fluid through Schlemm's canal in the eye comprising the steps of: a) positioning in Schlemm's canal a delivery tool comprising an implant, said implant comprising an elongated element with distal and proximal ends positionable within said canal so as to provide a tension to the inner wall of said canal to thereby increase fluid permeability of said inner wall; and a flexible delivery device attached to said implant ; b) releasing said implant from said tool in said canal; and c) connecting said distal and proximal ends of said implant and applying sufficient axial tensioning force to said implant to provide said tension on said inner wall to increase fluid permeability of said inner wall.
49. A method, for increasing the aqueous outflow of fluid through Schlemm' s canal in the eye comprising the steps of: a) positioning in Schlemm's canal a delivery tool comprising an implant, said implant comprising an elongated element with distal and proximal ends positionable within said canal so as to provide a tension to the inner wall of said canal to thereby increase fluid permeability of said inner wall; and a flexible delivery device attached to said implant ; b) securing one of said distal or proximal ends within said canal; c) adjusting said implant to apply sufficient axial tensioning force to said implant to provide said tension on said inner wall to increase fluid permeability of said inner wall; d) securing the other of said distal or proximal ends within said canal to maintain said tension on said inner wall.
50. A method according to Claim 48 or 49 wherein said flexible delivery device comprises a cannula.
51. A method according to Claim 48 or 49 wherein said flexible delivery device comprises a guidewire.
52. An implant according to any one of Claims 1 to 10 wherein said tension is axially applied to said wall,
53. An implant according to any one of Claims 12 to 35 wherein said tension is axially applied to said wall.
54. An implant according to Claim 36 wherein said tension is axially applied to said wall.
55. An implant according to Claim 37 wherein said tension is axially applied to said wall.
56. A tool according to Claim 38 wherein said tension is axially applied to said wall,
57. A method according to Claim 48 or 49 wherein said tension is axially applied to said wall.
58. A tool according to Claim 39 wherein said tension is axially applied to said wall.
59. An implant according to Claim 11 wherein said tension is axially applied to said wall.
60. A tool according to Claim 39 further comprising a guidance element for locating said tool during placement and advancement within Schlemm's canal.
61. A tool according to Claim 60 wherein said guidance element comprises a fiber optic beacon.
PCT/US2005/0456752004-12-162005-12-16Ophthalmic implant for treatment of glaucomaWO2006066103A2 (en)

Priority Applications (6)

Application NumberPriority DateFiling DateTitle
CA2592459ACA2592459C (en)2004-12-162005-12-16Ophthalmic implant for treatment of glaucoma
DE05854403TDE05854403T1 (en)2004-12-162005-12-16 OPHTHALMIC IMPLANT FOR GLUCKOMETRY
JP2007546947AJP5060960B6 (en)2004-12-162005-12-16 Ophthalmic implant for glaucoma treatment
EP05854403AEP1833440B1 (en)2004-12-162005-12-16Ophthalmic implant for treatment of glaucoma
AU2005316420AAU2005316420B2 (en)2004-12-162005-12-16Ophthalmic implant for treatment of glaucoma
BRPI0519087ABRPI0519087B8 (en)2004-12-162005-12-16 instrument for inserting an implant into the schlemm's canal of the eye

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
US63736804P2004-12-162004-12-16
US60/637,3682004-12-16

Publications (3)

Publication NumberPublication Date
WO2006066103A2 WO2006066103A2 (en)2006-06-22
WO2006066103A3 WO2006066103A3 (en)2006-09-08
WO2006066103B1true WO2006066103B1 (en)2006-10-26

Family

ID=36587389

Family Applications (1)

Application NumberTitlePriority DateFiling Date
PCT/US2005/045675WO2006066103A2 (en)2004-12-162005-12-16Ophthalmic implant for treatment of glaucoma

Country Status (9)

CountryLink
US (1)US8034105B2 (en)
EP (3)EP2505168A1 (en)
KR (1)KR20070092279A (en)
CN (1)CN101128171A (en)
AU (1)AU2005316420B2 (en)
BR (1)BRPI0519087B8 (en)
CA (1)CA2592459C (en)
DE (1)DE05854403T1 (en)
WO (1)WO2006066103A2 (en)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US8313454B2 (en)1997-11-202012-11-20Optonol Ltd.Fluid drainage device, delivery device, and associated methods of use and manufacture
ATE440580T1 (en)1999-04-262009-09-15Glaukos Corp SHUNTING DEVICE FOR GLAUCOMA TREATMENT
US6638239B1 (en)2000-04-142003-10-28Glaukos CorporationApparatus and method for treating glaucoma
US7867186B2 (en)2002-04-082011-01-11Glaukos CorporationDevices and methods for treatment of ocular disorders
US7431710B2 (en)2002-04-082008-10-07Glaukos CorporationOcular implants with anchors and methods thereof
CA2442652C (en)2001-04-072011-01-04Glaukos CorporationGlaucoma stent and methods thereof for glaucoma treatment
US7331984B2 (en)2001-08-282008-02-19Glaukos CorporationGlaucoma stent for treating glaucoma and methods of use
US20120010702A1 (en)*2004-12-162012-01-12Iscience Interventional CorporationOphthalmic implant for treatment of glaucoma
CN103183812B (en)2005-04-222016-03-02三菱化学株式会社 Polyesters from biomass resources and methods for their manufacture
US20070202186A1 (en)2006-02-222007-08-30Iscience Interventional CorporationApparatus and formulations for suprachoroidal drug delivery
WO2007139808A2 (en)*2006-05-252007-12-06Ayyala Ramesh SDevice for delivery of antifibrotic agents & method
US7909789B2 (en)*2006-06-262011-03-22Sight Sciences, Inc.Intraocular implants and methods and kits therefor
US8968396B2 (en)2007-07-232015-03-03Powervision, Inc.Intraocular lens delivery systems and methods of use
NZ583858A (en)*2007-09-072012-08-31Quadra Logic Tech IncLacrimal implant detection with detection device
CA2700503C (en)*2007-09-242016-05-24Ivantis, Inc.Ocular implants and methods
AU2014200768B2 (en)*2007-09-242016-03-03Alcon Inc.Ocular implants and methods
US8734377B2 (en)2007-09-242014-05-27Ivantis, Inc.Ocular implants with asymmetric flexibility
US20090082862A1 (en)2007-09-242009-03-26Schieber Andrew TOcular Implant Architectures
US7740604B2 (en)2007-09-242010-06-22Ivantis, Inc.Ocular implants for placement in schlemm's canal
US20170360609A9 (en)2007-09-242017-12-21Ivantis, Inc.Methods and devices for increasing aqueous humor outflow
US8512404B2 (en)*2007-11-202013-08-20Ivantis, Inc.Ocular implant delivery system and method
US8808222B2 (en)2007-11-202014-08-19Ivantis, Inc.Methods and apparatus for delivering ocular implants into the eye
CA3187608A1 (en)*2008-01-282009-08-06Implantica Patent Ltd.An implantable drainage device
US8109896B2 (en)*2008-02-112012-02-07Optonol Ltd.Devices and methods for opening fluid passageways
CA2717441A1 (en)2008-03-052009-09-11Ivantis, Inc.Methods and apparatus for treating glaucoma
EP2334268B1 (en)*2008-06-252017-08-02Novartis AgOcular implant with shape change capabilities
CN102238926B (en)2008-12-052015-09-16伊万提斯公司For ocular implants being transported to the method and apparatus in eyes
CH700161A2 (en)*2008-12-222010-06-30Grieshaber Ophthalmic Res FounIMPLANT FOR INTRODUCING into Schlemm's canal AN EYE.
JP2012526637A (en)*2009-05-152012-11-01アイサイエンス・インターベンショナル・コーポレーション Method and apparatus for subretinal catheter insertion
CN102596097B (en)2009-06-032015-05-20弗赛特实验室有限责任公司Anterior segment drug delivery
CN102481404B (en)2009-07-092014-03-05伊万提斯公司Ocular implants
CN102481171B (en)2009-07-092015-01-28伊万提斯公司Single operator device for delivering an ocular implant
US20120203160A1 (en)*2009-10-122012-08-09The Regents Of The University Of Colorado, A Body CorporateImplants for reducing intraocular pressure
JP2013508096A (en)*2009-10-232013-03-07イバンティス インコーポレイテッド Intraocular transplantation system and intraocular transplantation method
NL2004047C2 (en)*2010-01-042011-07-05D O R C Dutch Ophthalmic Res Ct International B VAn ophthalmic surgical device and a method of performing ophthalmic surgery.
WO2011097408A1 (en)2010-02-052011-08-11Sight Sciences, IncIntraocular implants and related kits and methods
EP2575715B1 (en)*2010-05-272014-10-29Ellex-iScience, Inc.Device for placing circumferential implant in schlemm's canal
US8545430B2 (en)2010-06-092013-10-01Transcend Medical, Inc.Expandable ocular devices
US9510973B2 (en)2010-06-232016-12-06Ivantis, Inc.Ocular implants deployed in schlemm's canal of the eye
CN101889882A (en)*2010-07-222010-11-24姚万钧Medicinal guide wire
CN103327939B (en)2010-10-152017-05-24科尼尔赛德生物医学公司Device for ocular access
RU2598057C2 (en)*2011-02-042016-09-20ТАРИС Биомедикал ЛЛКImplantable device for controlled release of drug with low solubility
JP5902720B2 (en)2011-02-232016-04-13グリースハーバー オフサルミック リサーチ ファンデーションＧｒｉｅｓｈａｂｅｒ Ｏｐｈｔｈａｌｍｉｃ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ Implants for treating glaucoma
US8747299B2 (en)2011-06-022014-06-10Grieshaber Ophtalmic Research FoundationMethod and device for the pathology analysis of the Schlemm's canal
US8657776B2 (en)2011-06-142014-02-25Ivantis, Inc.Ocular implants for delivery into the eye
CN102824238B (en)*2011-06-162014-07-09王宁利Schlemm tube expansion bracket and combined body thereof
EP2755615B1 (en)2011-09-142022-04-06Forsight Vision5, Inc.Ocular insert apparatus
US8663150B2 (en)2011-12-192014-03-04Ivantis, Inc.Delivering ocular implants into the eye
WO2013115861A2 (en)*2012-02-032013-08-08Innovative Glaucoma Solutions, LlcMethod and apparatus for treating an ocular disorder
EP4302734A3 (en)2012-03-202024-03-20Sight Sciences, Inc.Ocular delivery systems and methods
CA3098762C (en)2012-03-262023-01-17Glaukos CorporationSystem and method for delivering multiple ocular implants
US9358156B2 (en)2012-04-182016-06-07Invantis, Inc.Ocular implants for delivery into an anterior chamber of the eye
US9308082B2 (en)*2012-08-072016-04-12RegenEye, L.L.C.Ocular collar stent for treating narrowing of the irideocorneal angle
US20140060159A1 (en)*2012-08-312014-03-06Johnson & Johnson Consumer Companies, Inc.Permeability flow cell and hydraulic conductance system
HUE046128T2 (en)2012-10-262020-02-28Forsight Vision5 IncOphthalmic system for sustained release of drug to eye
US10617558B2 (en)2012-11-282020-04-14Ivantis, Inc.Apparatus for delivering ocular implants into an anterior chamber of the eye
EP2967842B1 (en)2013-03-152020-11-04Alcon Inc.Method of reconfiguring an intraocular lens for delivery to a delivery device
US10517759B2 (en)2013-03-152019-12-31Glaukos CorporationGlaucoma stent and methods thereof for glaucoma treatment
SG10201702674PA (en)2013-05-032017-06-29Clearside Biomedical IncApparatus and methods for ocular injection
CN103251479B (en)*2013-05-222014-10-29王宁利Schlemm canal expansion stent
US10010447B2 (en)2013-12-182018-07-03Novartis AgSystems and methods for subretinal delivery of therapeutic agents
US9205181B2 (en)2014-01-092015-12-08Rainbow Medical, Ltd.Injectable hydrogel implant for treating glaucoma
JP6655610B2 (en)2014-05-292020-02-26グローコス コーポレーション IMPLANT WITH CONTROLLED DRUG DELIVERY FUNCTION AND METHOD OF USING THE SAME
US10709547B2 (en)2014-07-142020-07-14Ivantis, Inc.Ocular implant delivery system and method
US10507101B2 (en)2014-10-132019-12-17W. L. Gore & Associates, Inc.Valved conduit
US10299958B2 (en)2015-03-312019-05-28Sight Sciences, Inc.Ocular delivery systems and methods
US20160296532A1 (en)2015-04-132016-10-13Forsight Vision5, Inc.Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
US11197779B2 (en)2015-08-142021-12-14Ivantis, Inc.Ocular implant with pressure sensor and delivery system
US11925578B2 (en)2015-09-022024-03-12Glaukos CorporationDrug delivery implants with bi-directional delivery capacity
US11938058B2 (en)2015-12-152024-03-26Alcon Inc.Ocular implant and delivery system
CN105769433A (en)*2016-01-082016-07-20王素常Screw type Schlemm tube stent
WO2017192565A1 (en)2016-05-022017-11-09Clearside Biomedical, Inc.Systems and methods for ocular drug delivery
CN110177527B (en)2016-08-122022-02-01科尼尔赛德生物医学公司Device and method for adjusting insertion depth of needle for medicament delivery
US11351058B2 (en)2017-03-172022-06-07W. L. Gore & Associates, Inc.Glaucoma treatment systems and methods
CN107174397A (en)*2017-06-292017-09-19天津优视眼科技术有限公司A kind of therapeutic system of ophthalmology targeting implantation support
US11116625B2 (en)2017-09-282021-09-14Glaukos CorporationApparatus and method for controlling placement of intraocular implants
US11576816B2 (en)2017-10-182023-02-14Jesus MorenoOpthalmic microsurgical instrument
US10987247B2 (en)2017-10-182021-04-27Jesus MorenoOpthalmic microsurgical instrument
CN107837139B (en)*2017-12-042024-07-09广州聚明生物科技有限公司Aqueous humor drainage device and manufacturing method thereof
AU2019223946B2 (en)2018-02-222021-05-20Alcon Inc.Ocular implant and delivery system
WO2020047221A1 (en)2018-08-292020-03-05W. L. Gore & Associates, Inc.Drug therapy delivery systems and methods
US11678983B2 (en)2018-12-122023-06-20W. L. Gore & Associates, Inc.Implantable component with socket
WO2020186293A1 (en)*2019-03-152020-09-24Minas Theodore CoroneoOphthalmic compositions, and ocular uses thereof, of indigo carmine
CN114502098A (en)2019-07-102022-05-13阿奎健康公司 Eye stents and delivery systems
US11259961B2 (en)2019-07-222022-03-01Iantrek, Inc.Methods and devices for increasing aqueous drainage of the eye
US11504270B1 (en)2019-09-272022-11-22Sight Sciences, Inc.Ocular delivery systems and methods
AU2022205382A1 (en)2021-01-112023-06-22Alcon Inc.Systems and methods for viscoelastic delivery
US12310892B2 (en)2021-09-102025-05-27Iantrek, Inc.Methods and devices for increasing aqueous drainage of the eye
US12245930B2 (en)2023-06-302025-03-11Alcon Inc.System and methods for compensating for intraocular lens tilt

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5360399A (en)1992-01-101994-11-01Robert StegmannMethod and apparatus for maintaining the normal intraocular pressure
US6102045A (en)*1994-07-222000-08-15Premier Laser Systems, Inc.Method and apparatus for lowering the intraocular pressure of an eye
US5485165A (en)*1994-08-151996-01-16The United States Of America As Represented By The Secretary Of The ArmyBroadband high efficiency full wave open coaxial stub loop antenna
EP0898947A3 (en)1997-08-151999-09-08GRIESHABER & CO. AG SCHAFFHAUSENMethod and apparatus to improve the outflow of the aqueous humor of an eye
AU5339099A (en)*1998-08-052000-02-28Keravision, Inc.Corneal implant with migration preventer
DE19840047B4 (en)*1998-09-022004-07-08Neuhann, Thomas, Prof.Dr.med. Device for the targeted improvement and / or permanent guarantee of the permeability for eye chamber water through the trabecular mechanism in the Schlemm's Canal
ATE440580T1 (en)*1999-04-262009-09-15Glaukos Corp SHUNTING DEVICE FOR GLAUCOMA TREATMENT
US20050119601A9 (en)*1999-04-262005-06-02Lynch Mary G.Shunt device and method for treating glaucoma
US6221078B1 (en)*1999-06-252001-04-24Stephen S. BylsmaSurgical implantation apparatus
US6726676B2 (en)2000-01-052004-04-27Grieshaber & Co. Ag SchaffhausenMethod of and device for improving the flow of aqueous humor within the eye
US6375642B1 (en)*2000-02-152002-04-23Grieshaber & Co. Ag SchaffhausenMethod of and device for improving a drainage of aqueous humor within the eye
US7867186B2 (en)*2002-04-082011-01-11Glaukos CorporationDevices and methods for treatment of ocular disorders
US20020143284A1 (en)2001-04-032002-10-03Hosheng TuDrug-releasing trabecular implant for glaucoma treatment
US6533768B1 (en)2000-04-142003-03-18The Regents Of The University Of CaliforniaDevice for glaucoma treatment and methods thereof
US6638239B1 (en)*2000-04-142003-10-28Glaukos CorporationApparatus and method for treating glaucoma
US7708711B2 (en)*2000-04-142010-05-04Glaukos CorporationOcular implant with therapeutic agents and methods thereof
JP3364654B2 (en)*2000-05-312003-01-08独立行政法人産業技術総合研究所 Virtual form generation apparatus and generation method
CA2407953A1 (en)2000-06-192001-12-27Glaukos CorporationStented trabecular shunt and methods thereof
FR2813521B1 (en)*2000-09-012003-06-13Ioltechnologie Production GLAUCOME DRAIN
US6962573B1 (en)*2000-10-182005-11-08Wilcox Michael JC-shaped cross section tubular ophthalmic implant for reduction of intraocular pressure in glaucomatous eyes and method of use
WO2002036052A1 (en)2000-11-012002-05-10Glaukos CorporationGlaucoma treatment device
US6692524B2 (en)*2001-01-192004-02-17Georges BaikoffTechniques and implants for correcting presbyopia
WO2002074052A2 (en)2001-03-162002-09-26Glaukos CorporationApplicator and methods for placing a trabecular shunt for glaucoma treatment
CA2442652C (en)*2001-04-072011-01-04Glaukos CorporationGlaucoma stent and methods thereof for glaucoma treatment
US6666841B2 (en)2001-05-022003-12-23Glaukos CorporationBifurcatable trabecular shunt for glaucoma treatment
US8267995B2 (en)*2001-08-032012-09-18David CastillejosMethod and intra sclera implant for treatment of glaucoma and presbyopia
JP2005525835A (en)2001-08-162005-09-02ジーエムピー ヴィジョン ソルーションズ インコーポレイテッド Improved short circuit device and improved short circuit method for treating glaucoma
EP1455698A1 (en)*2001-11-212004-09-15Iscience CorporationOphthalmic microsurgical system
US7186232B1 (en)*2002-03-072007-03-06Glaukoa CorporationFluid infusion methods for glaucoma treatment
US20040024345A1 (en)*2002-04-192004-02-05Morteza GharibGlaucoma implant with valveless flow bias
US20070073275A1 (en)2003-04-162007-03-29Conston Stanley ROphthalmic microsurgical instruments
EP1737531A2 (en)*2004-04-232007-01-03Gmp Vision Solutions, Inc.Indwelling shunt device and methods for treating glaucoma

Also Published As

Publication numberPublication date
EP2215996B1 (en)2013-04-03
AU2005316420B2 (en)2011-11-10
JP2008523917A (en)2008-07-10
KR20070092279A (en)2007-09-12
WO2006066103A2 (en)2006-06-22
AU2005316420A1 (en)2006-06-22
EP2215996A2 (en)2010-08-11
CN101128171A (en)2008-02-20
CA2592459A1 (en)2006-06-22
WO2006066103A3 (en)2006-09-08
US20060195187A1 (en)2006-08-31
US8034105B2 (en)2011-10-11
EP2215996A3 (en)2010-09-08
EP1833440A2 (en)2007-09-19
DE05854403T1 (en)2010-08-26
CA2592459C (en)2017-08-22
BRPI0519087B8 (en)2021-06-22
JP5060960B2 (en)2012-10-31
BRPI0519087B1 (en)2020-09-24
EP2505168A1 (en)2012-10-03
BRPI0519087A2 (en)2008-12-23
EP1833440B1 (en)2012-08-22

Similar Documents

PublicationPublication DateTitle
WO2006066103B1 (en)Ophthalmic implant for treatment of glaucoma
US20200121504A1 (en)Ophthalmic implant for treatment of glaucoma
US9561132B2 (en)Method and device for the treatment of glaucoma
US10154924B2 (en)Schlemm's canal devices and method for improving fluid flow
US20140031737A1 (en)Expandable ocular devices
ES2733442T3 (en) Device for treatment of retinal detachment and other eye diseases
US20070027452A1 (en)Insertion instrument for non-linear medical devices
JP2018528808A (en) Sinus and nasal stents
WO2011020633A1 (en)Method and device for the treatment of glaucoma
AU2005206212A1 (en)Composite ophthalmic microcannula
JP2003524466A (en) Inflatable device and method for treating glaucoma
WO2005105197A2 (en)Indwelling shunt device and methods for treating glaucoma
WO2018232248A1 (en)Modular glaucoma implant
US12083044B2 (en)Eye stents and delivery systems
US20140336619A1 (en)Ophthalmic shunt and method
US9445941B2 (en)Bioresorbable drug eluting intravitreal implant system and method
AU2012200785A1 (en)Ophthalmic implant for treatment of glaucoma
HK1117024A (en)Ophthalmic implant for treatment of glaucoma
JP5060960B6 (en) Ophthalmic implant for glaucoma treatment
CN119344949A (en) Implants and implant delivery devices
AU2011221361A1 (en)Composite Ophthalmic Microcannula
HK1095260B (en)Composite ophthalmic microcannula

Legal Events

DateCodeTitleDescription
AKDesignated states

Kind code of ref document:A2

Designated state(s):AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

ALDesignated countries for regional patents

Kind code of ref document:A2

Designated state(s):BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWEWipo information: entry into national phase

Ref document number:2592459

Country of ref document:CA

WWEWipo information: entry into national phase

Ref document number:2005316420

Country of ref document:AU

Ref document number:2007546947

Country of ref document:JP

NENPNon-entry into the national phase

Ref country code:DE

WWEWipo information: entry into national phase

Ref document number:2005854403

Country of ref document:EP

ENPEntry into the national phase

Ref document number:2005316420

Country of ref document:AU

Date of ref document:20051216

Kind code of ref document:A

WWPWipo information: published in national office

Ref document number:2005316420

Country of ref document:AU

WWEWipo information: entry into national phase

Ref document number:1020077016058

Country of ref document:KR

WWEWipo information: entry into national phase

Ref document number:200580048330.7

Country of ref document:CN

121Ep: the epo has been informed by wipo that ep was designated in this application
WWPWipo information: published in national office

Ref document number:2005854403

Country of ref document:EP

ENPEntry into the national phase

Ref document number:PI0519087

Country of ref document:BR
[8]ページ先頭
©2009-2025 Movatter.jp